164 related articles for article (PubMed ID: 29920587)
1. GC-MS and GC-IR Analyses of the Methoxy-1-n-pentyl-3-(1-naphthoyl)-indoles: Regioisomeric Designer Cannabinoids.
Thaxton-Weissenfluh A; Belal TS; DeRuiter J; Smith F; Abiedalla Y; Neel L; Abdel-Hay KM; Clark CR
J Chromatogr Sci; 2018 Oct; 56(9):779-788. PubMed ID: 29920587
[TBL] [Abstract][Full Text] [Related]
2. GC-MS studies on the six naphthoyl-substituted 1-n-pentyl-indoles: JWH-018 and five regioisomeric equivalents.
Thaxton A; Belal TS; Smith F; DeRuiter J; Abdel-Hay KM; Clark CR
Forensic Sci Int; 2015 Jul; 252():107-13. PubMed ID: 25965306
[TBL] [Abstract][Full Text] [Related]
3. Analytical studies on the 2-naphthoyl substituted-1-n-pentylindoles: Regioisomeric synthetic cannabinoids.
Thaxton-Weissenfluh A; Alsegiani AS; Abiedalla Y; DeRuiter J; Smith F; Clark CR
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1077-1078():77-84. PubMed ID: 29413581
[TBL] [Abstract][Full Text] [Related]
4. Gas Chromatography-Mass Spectrometry (GC-MS) and Gas Chromatography-Infrared (GC-IR) Analyses of the Chloro-1- n-pentyl-3-(1-naphthoyl)-Indoles: Regioisomeric Cannabinoids.
Abdel-Hay KM; Belal TS; Abiedalla Y; Thaxton-Weissenfluh A; DeRuiter J; Smith F; Clark CR
Appl Spectrosc; 2019 Apr; 73(4):433-443. PubMed ID: 30347999
[TBL] [Abstract][Full Text] [Related]
5. Mass spectral studies on 1-n-pentyl-3-(1-naphthoyl)indole (JWH-018), three deuterium-labeled analogues and the inverse isomer 1-naphthoyl-3-n-pentylindole.
Thaxton A; Belal TS; Smith F; DeRuiter J; Abdel-Hay KM; Clark CR
Rapid Commun Mass Spectrom; 2015 May; 29(9):871-7. PubMed ID: 26377015
[TBL] [Abstract][Full Text] [Related]
6. GC-MS and FTIR evaluation of the six benzoyl-substituted-1-pentylindoles: isomeric synthetic cannabinoids.
Smith FT; DeRuiter J; Abdel-Hay K; Clark CR
Talanta; 2014 Nov; 129():171-82. PubMed ID: 25127581
[TBL] [Abstract][Full Text] [Related]
7. Correlation of vapor phase infrared spectra and regioisomeric structure in synthetic cannabinoids.
Smith LW; Thaxton-Weissenfluh A; Abiedalla Y; DeRuiter J; Smith F; Clark CR
Spectrochim Acta A Mol Biomol Spectrosc; 2018 May; 196():375-384. PubMed ID: 29486418
[TBL] [Abstract][Full Text] [Related]
8. GC-MS differentiation of the six regioisomeric dimethoxybenzoyl-1-pentylindoles: Isomeric cannabinoid substances.
Abdel-Hay KM; De Ruiter J; Smith F; Alsegiani AS; Thaxton-Weissenfluh A; Clark CR
J Pharm Biomed Anal; 2016 Jun; 125():360-8. PubMed ID: 27107854
[TBL] [Abstract][Full Text] [Related]
9. Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS.
Kusano M; Zaitsu K; Nakayama H; Nakajima J; Hisatsune K; Moriyasu T; Matsuta S; Katagi M; Tsuchihashi H; Ishii A
J Mass Spectrom; 2015 Mar; 50(3):586-91. PubMed ID: 25800195
[TBL] [Abstract][Full Text] [Related]
10. GC-MS analysis of the regioisomeric methoxy- and methyl-benzoyl-1-pentylindoles: Isomeric synthetic cannabinoids.
Abdel-Hay KM; DeRuiter J; Smith F; Belal TS; Clark CR
Sci Justice; 2015 Sep; 55(5):291-8. PubMed ID: 26385710
[TBL] [Abstract][Full Text] [Related]
11. Development of a mass spectrometric hydroxyl-position determination method for the hydroxyindole metabolites of JWH-018 by GC-MS/MS.
Kusano M; Zaitsu K; Yamanaka M; Hisatsune K; Asano T; Taki K; Hayashi Y; Tsuchihashi H; Ishii A
J Mass Spectrom; 2016 May; 51(5):350-7. PubMed ID: 27194519
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of methoxybenzoylpiperazines (OMeBzPs) and methylenedioxybenzylpiperazines (MDBPs) By GC-IRD and GC-MS.
Abdel-Hay KM; DeRuiter J; Clark CR
Drug Test Anal; 2012 Jun; 4(6):430-40. PubMed ID: 22170873
[TBL] [Abstract][Full Text] [Related]
13. Analytical differentiation of 1-alkyl-3-acylindoles and 1-acyl-3-alkylindoles: isomeric synthetic cannabinoids.
DeRuiter J; Smith FT; Abdel-Hay K; Clark CR
Anal Chem; 2014 Apr; 86(8):3801-8. PubMed ID: 24611491
[TBL] [Abstract][Full Text] [Related]
14. CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate.
Kondrasenko AA; Goncharov EV; Dugaev KP; Rubaylo AI
Forensic Sci Int; 2015 Dec; 257():209-213. PubMed ID: 26386336
[TBL] [Abstract][Full Text] [Related]
15. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
[TBL] [Abstract][Full Text] [Related]
16. Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone.
Carlsson A; Lindberg S; Wu X; Dunne S; Josefsson M; Åstot C; Dahlén J
Drug Test Anal; 2016 Oct; 8(10):1015-1029. PubMed ID: 26526273
[TBL] [Abstract][Full Text] [Related]
17. Characterization of in vitro metabolites of JWH-018, JWH-073 and their 4-methyl derivatives, markers of the abuse of these synthetic cannabinoids.
Gambaro V; Arnoldi S; Bellucci S; Casagni E; Dell'Acqua L; Fumagalli L; Pallavicini M; Roda G; Rusconi C; Valoti E
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():68-76. PubMed ID: 24657413
[TBL] [Abstract][Full Text] [Related]
18. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: a snapshot of the German situation in the autumn of 2012.
Langer N; Lindigkeit R; Schiebel HM; Ernst L; Beuerle T
Drug Test Anal; 2014; 6(1-2):59-71. PubMed ID: 23723183
[TBL] [Abstract][Full Text] [Related]
19. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs).
Rösner P; Quednow B; Girreser U; Junge T
Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cannabis.
Westin AA; Brede WR; Espnes KA
Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2289. PubMed ID: 23736197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
